Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 925485, 9 pages
http://dx.doi.org/10.1155/2014/925485
Review Article

Prevention and Restoration of Hearing Loss Associated with the Use of Cisplatin

1Otolaryngology Department, Military Hospital Cluj-Napoca, 22 General Traian Mosoiu Street, 3400 Cluj-Napoca, Romania
2II-nd Department of Otolaryngology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, Strada Republicii 18, 400015 Cluj-Napoca, Romania

Received 2 May 2014; Accepted 10 July 2014; Published 22 July 2014

Academic Editor: Srdjan Vlajkovic

Copyright © 2014 Felician Chirtes and Silviu Albu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Gonçalves, A. F. Silveira, A. R. Teixeira, and M. A. Hyppolito, “Mechanisms of cisplatin ototoxicity: theoretical review,” Journal of Laryngology and Otology, vol. 127, no. 6, pp. 536–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Schacht, A. E. Talaska, and L. P. Rybak, “Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention,” The Anatomical Record, vol. 295, no. 11, pp. 1837–1850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Marshak, M. Steiner, M. Kaminer, L. Levy, and A. Shupak, “Prevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled study,” Otolaryngology—Head and Neck Surgery, vol. 150, no. 6, pp. 983–990, 2014. View at Publisher · View at Google Scholar
  4. S. Waissbluth, P. Salehi, X. He, and S. J. Daniel, “Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity,” European Archives of Oto-Rhino-Laryngology, vol. 270, no. 5, pp. 1597–1605, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Kuduban, C. Kucur, E. Sener, H. Suleyman, and F. Akcay, “The role of thiamine pyrophosphate in prevention of cisplatin ototoxicity in an animal model,” The Scientific World Journal, vol. 2013, Article ID 182694, 5 pages, 2013. View at Publisher · View at Google Scholar
  6. M. Ozturk, S. Ucar, F. Sari, S. Erdogan, M. Topdag, and M. Iseri, “Possible protective effect of sertraline against cisplatin-induced ototoxicity: an experimental study,” The Scientific World Journal, vol. 2013, Article ID 523480, 5 pages, 2013. View at Publisher · View at Google Scholar
  7. S. Jamesdaniel, S. Manohar, and S. Hinduja, “Is S-nitrosylation of cochlear proteins a critical factor in cisplatin-induced ototoxicity?” Antioxidants & Redox Signaling, vol. 17, no. 7, pp. 929–933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Alam, K. Ikeda, T. Oshima et al., “Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea,” Hearing Research, vol. 141, no. 1-2, pp. 28–38, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Eiamprapai, N. Yamamoto, H. Hiraumi et al., “Effect of cisplatin on distortion product otoacoustic emissions in Japanese patients,” Laryngoscope, vol. 122, no. 6, pp. 1392–1396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. R. Knight, D. P. Kraemer, C. Winter, and E. A. Neuwelt, “Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions,” Journal of Clinical Oncology, vol. 25, no. 10, pp. 1190–1195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. L. Zuur, Y. J. W. Simis, P. E. M. Lansdaal et al., “Audiometric patterns in ototoxicity of intra-arterial cisplatin chemoradiation in patients with locally advanced head and neck cancer,” Audiology and Neurotology, vol. 11, no. 5, pp. 318–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Warrier, A. Chauhan, M. Davluri, S. L. Tedesco, J. Nadell, and R. Craver, “Cisplatin and cranial irradiation-related hearing loss in children,” The Ochsner Journal, vol. 12, no. 3, pp. 191–196, 2012. View at Google Scholar · View at Scopus
  13. J. R. García-Berrocal, J. Nevado, R. Ramírez-Camacho et al., “The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear,” British Journal of Pharmacology, vol. 152, no. 7, pp. 1012–1020, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. G. Shafik, R. H. Elkabarity, M. T. Thabet, N. B. Soliman, and N. K. Kalleny, “Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs,” Auris Nasus Larynx, vol. 40, no. 1, pp. 51–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Hellberg, I. Wallin, H. Ehrsson, and G. Laurell, “Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig,” The Laryngoscope, vol. 123, no. 12, pp. 3172–3177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. P. Rybak, D. Mukherjea, S. Jajoo, and V. Ramkumar, “Cisplatin ototoxicity and protection: clinical and experimental studies,” Tohoku Journal of Experimental Medicine, vol. 219, no. 3, pp. 177–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Yassuda, A. Righetti, M. Cury, M. Hyppolito, J. A. de Oliveira, and O. Féres, “The role of hyperbaric oxygen therapy (hot) as an otoprotection agent against cisplatin ototoxicity,” Acta Cirurgica Brasileira, vol. 23, supplement 1, pp. 72–76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. C. Schmitt, E. W. Rubel, and N. M. Nathanson, “Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate,” Journal of Neuroscience, vol. 29, no. 12, pp. 3843–3851, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Choe, N. Chinosornvatana, and K. W. Chang, “Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate,” Otology and Neurotology, vol. 25, no. 6, pp. 910–915, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Nader, Y. Théorêt, and I. Saliba, “The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity,” Laryngoscope, vol. 120, no. 6, pp. 1208–1213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Malberg and J. A. Blendy, “Antidepressant action: to the nucleus and beyond,” Trends in Pharmacological Sciences, vol. 26, no. 12, pp. 631–638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Drottar, M. C. Liberman, R. R. Ratan, and D. W. Roberson, “The histone deacetylase inhibitor sodium butyrate protects against cisplatin-induced hearing loss in guinea pigs,” The Laryngoscope, vol. 116, no. 2, pp. 292–296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kaur, D. Mukherjea, K. Sheehan, S. Jajoo, L. P. Rybak, and V. Ramkumar, “Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation,” Cell Death and Disease, vol. 2, article e180, 2011. View at Publisher · View at Google Scholar
  24. D. Mukherjea, S. Jajoo, T. Kaur, K. E. Sheehan, V. Ramkumar, and L. P. Rybak, “Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat,” Antioxidants and Redox Signaling, vol. 13, no. 5, pp. 589–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Lee, J. Shin, and Y. Cho, “Protective effect of minocycline against cisplatin-induced ototoxicity,” Clinical and Experimental Otorhinolaryngology, vol. 4, no. 2, pp. 77–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Waissbluth, I. Dupuis, and S. J. Daniel, “Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model,” Otolaryngology—Head and Neck Surgery, vol. 146, no. 4, pp. 627–632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. G. W. Hill, D. K. Morest, and K. Parham, “Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections,” Otology & Neurotology, vol. 29, no. 7, pp. 1005–1011, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Murphy and S. J. Daniel, “Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model,” Otolaryngology: Head and Neck Surgery, vol. 145, no. 3, pp. 452–457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Herr, E. Ucur, K. Herzer et al., “Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas,” Cancer Research, vol. 63, no. 12, pp. 3112–3120, 2003. View at Google Scholar · View at Scopus
  30. K. Parham, “Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?” Otolaryngology—Head and Neck Surgery, vol. 145, no. 4, pp. 635–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. L. Hughes, N. Hussain, R. Pafford, and K. Parham, “Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model,” Otolaryngology—Head and Neck Surgery, vol. 150, no. 1, pp. 115–120, 2014. View at Publisher · View at Google Scholar
  32. H.-J. Jeong, Y. Choi, M.-H. Kim et al., “Rosmarinic acid, active component of dansam-eum attenuates ototoxicity of cochlear hair cells through blockage of caspase-1 activity,” PLoS ONE, vol. 6, no. 4, Article ID e18815, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Kasse, O. L. M. Cruz, L. C. N. Iha, H. O. Costa, E. C. Lopes, and F. Coelho, “The use of Maytenus ilicifolia to prevent cisplatin-induced ototoxicity,” Brazilian Journal of Otorhinolaryngology, vol. 74, no. 5, pp. 712–717, 2008. View at Google Scholar · View at Scopus
  34. Y. Olgun, Z. Altun, S. Aktas et al., “Molecular mechanisms of protective effect of resveratrol against cisplatinium induced ototoxicity,” Journal of International Advanced Otology, vol. 9, no. 2, p. 415, 2013. View at Google Scholar
  35. Y. Olgun, G. Kirkim, E. Kolatan, and M. Kiray, “Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity,” Laryngoscope, vol. 124, no. 3, pp. 760–766, 2014. View at Google Scholar
  36. A. C. Yumusakhuylu, M. Yazici, M. Sari et al., “Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs,” International Journal of Pediatric Otorhinolaryngology, vol. 76, no. 3, pp. 404–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. A. McCall, E. E. L. Swan, J. T. Borenstein, W. F. Sewell, S. G. Kujawa, and M. J. McKenna, “Drug delivery for treatment of inner ear disease: current state of knowledge,” Ear and Hearing, vol. 31, no. 2, pp. 156–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Yoo, S. Hamilton, D. Angel et al., “Cisplatin otoprotection using transtympanic L-N-Acetylcysteine: a pilot randomized study in head and neck cancer patients,” Laryngoscope, vol. 124, pp. E87–EE94, 2014. View at Google Scholar
  39. J. D. Borsi, C. Csaki, T. Ferencz, and W. Oster, “Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin,” Anti-Cancer Drugs, vol. 7, no. 1, pp. 121–126, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Marina, K. W. Chang, M. Malogolowkin et al., “Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors,” Cancer, vol. 104, no. 4, pp. 841–847, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Waissbluth, J. Pitaro, and S. J. Daniel, “Gene therapy for cisplatin-induced ototoxicity: a systematic review of in vitro and experimental animal studies,” Otology & Neurotology, vol. 33, no. 3, pp. 302–310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Wyatt and M. Jayne, “Cisplatin-induced ototoxicity and the role of pharmacogenetic testing,” Journal of Pediatric Pharmacology and Therapeutics, vol. 17, no. 4, pp. 395–399, 2012. View at Google Scholar
  43. D. Mukherjea and L. P. Rybak, “Pharmacogenomics of cisplatin-induced ototoxicity,” Pharmacogenomics, vol. 12, no. 7, pp. 1039–1050, 2011. View at Publisher · View at Google Scholar · View at Scopus